Birdshot Chorioretinopathy in Early Adulthood: Review of Current Literature and Case Report

References

• Franceschetti A, Babel J. Chorioretinitis With “Candle Spots”. a manifestation of Besnier-BoeckDisease. Ophthalmologica. 1949;118(4–5):701–710. doi:10.1159/000300769
   PubMedGoogle Scholar
• Gasch AT, Smith JA, Withcup SM. Birdshot retinochoroidopathy. Br J Ophthalmol. 1999;83(2):241–249.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114(5):593–599. doi:10.1001/archopht.1996.01100130585016
   PubMed Web of Science ®Google Scholar
• Minos E, Barry RJ, Southworth S, et al. Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment. Text Orphanet J Rare Dis. 2016;11:61.
   PubMed Web of Science ®Google Scholar
• Jones NP. The Manchester uveitis clinic: the first 3000 patients--epidemiology and casemix. Ocul Immunol Inflamm. 2015;23(2):118–126. doi:10.3109/09273948.2013.855799
   PubMed Web of Science ®Google Scholar
• Shah KH, Yu F, Goldhardt R, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50(6):519–541.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94(2):147–158.
   PubMed Web of Science ®Google Scholar
• Kiss S, Stephen Foster C. Birdshot retinochoroidopathy. Int Ophthalmol Clin. 2020;46(2):39–55.
   Google Scholar
• Donvito B, Monnet D, Tabary T, et al. Different HLA class IA region complotypes for HLA-A29.2 and -A29.1 antigens, identical in birdshot retinochoroidopathy patients or healthy individuals. Invest Ophthalmol Vis Sci. 2005;46(9):3227–3232. doi:10.1167/iovs.04-0858
   PubMed Web of Science ®Google Scholar
• Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci. 2001;98(5):2572–2576. doi:10.1073/pnas.051595998
   PubMed Web of Science ®Google Scholar
• Kuiper JJ, Mutis T, de Jager W, de Groot-Mijnes JD, Rothova A. Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am J Ophthalmol. 2011;152(2):177–182. doi:10.1016/j.ajo.2011.01.031
   PubMed Web of Science ®Google Scholar
• Gaudio PA, Kaye DB, Crawford JB. Histopathology of birdshot retinochoroidopathy. Text Br J Ophthalmol. 2002;86(12):1439–1441. doi:10.1136/bjo.86.12.1439
   PubMed Web of Science ®Google Scholar
• Rothova A, Probst K, van Kooij B, Baarsma GS. Birdshot chorioretinopathy: long-term manifestations and visual prognosis. Ophthalmology. 2004;111(5):954–959.
   PubMed Web of Science ®Google Scholar
• Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol. 1988;72(9):646–659. doi:10.1136/bjo.72.9.646
   PubMed Web of Science ®Google Scholar
• Pagnoux C, Mahr A, Aouba A, et al. Extraocular manifestations of birdshot chorioretinopathy in 118 French Patients. Presse Med. 2010;39(5):e97–e102. doi:10.1016/j.lpm.2009.12.005
   PubMedGoogle Scholar
• Standardization of Uveitis Nomenclature Working G. Classification criteria for birdshot chorioretinitis. Am J Ophthalmol. 2021;228:65–71. doi:10.1016/j.ajo.2021.03.059
   PubMed Web of Science ®Google Scholar
• Levinson RD, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conferences. Am J Ophthalmol. 2006;141(1):185–187.
   PubMed Web of Science ®Google Scholar
• Guex-Crosier Y, Herbort CP. Prolonged retinal arterio-venous circulation time by fluorescein but not by indocyanine green angiography in birdshot chorioretinopathy. Ocul Immunol Inflamm. 1997;5(3):203–206. doi:10.3109/09273949709116895
   PubMed Web of Science ®Google Scholar
• Fardeau C, Herbort CP, Kullmann N, Quentel G, LeHoang P. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology. 1999;106(10):1928–1934. doi:10.1016/S0161-6420(99)90403-7
   PubMed Web of Science ®Google Scholar
• Mailhac A, Aptel F, Berthemy S, Bouillet L, Chiquet C. Five-year trends in multifocal electroretinogram for patients with birdshot chorioretinopathy. Am J Ophthalmol. 2019;200:138–149.
   PubMed Web of Science ®Google Scholar
• Menezo V, Taylor SR. Birdshot uveitis: current and emerging treatment options. Clin Ophthalmol. 2014;8:73–81. doi:10.2147/OPTH.S54832
   PubMedGoogle Scholar
• Pivetti-Pezzi P. Uveitis in Children. Eur J Ophthalmol. 1996;2:6.
   Google Scholar
• Lee J, Smith WM, Goldstein DA. Birdshot chorioretinopathy presenting in a teenager. Am J Ophthalmol Case Rep. 2020;19:100807. doi:10.1016/j.ajoc.2020.100807
   PubMedGoogle Scholar
• Leclercq M, Le Besnerais M, Langlois V, et al. Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review. Clin Rheumatol. 2018;37(3):849–853. doi:10.1007/s10067-018-4007-4
   PubMed Web of Science ®Google Scholar
• Phasukkijwatana N, Iafe N, Sarraf D. Optical coherence tomography angiography of A29 birdshot chorioretinopathy complicated by retinal neovascularization. Retin Case Bri Rep. 2017;11(Suppl 1):S68–S72. doi:10.1097/ICB.0000000000000418
   PubMedGoogle Scholar
• Calvo-Río V, Blanco R, Santos-Gómez M, et al. Efficacy of anti-IL6-receptor tocilizumab in refractory cystoid macular edema of birdshot retinochoroidopathy report of two cases and literature review. Ocul Immunol Inflamm. 2017;25(5):604–609. doi:10.1080/09273948.2016.1231331
   PubMed Web of Science ®Google Scholar
• Carlson RW, Theriault R, Schurman CM, et al. Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women. J Clin Oncol. 2010;28(25):3917–3921. doi:10.1200/JCO.2009.24.9565
   PubMed Web of Science ®Google Scholar
• Keane PA, Allie M, Turner SJ, et al. Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography. JAMA Ophthalmology. 2013;131(3):341–350. doi:10.1001/jamaophthalmol.2013.1724
   PubMed Web of Science ®Google Scholar
• Trinh L, Bodaghi B, Fardeau C, et al. Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families. Am J Ophthalmol. 2009;147(6):1042–1047. doi:10.1016/j.ajo.2008.12.035
   PubMed Web of Science ®Google Scholar
• Lim L, Harper A, Guymer R. Choroidal lesions preceding symptom onset in birdshot chorioretinopathy. Arch Ophthalmol. 2006;124(7):1057–1058. doi:10.1001/archopht.124.7.1057
   PubMedGoogle Scholar
• Becker MD, Wertheim MS, Smith JR, Rosenbaum JT. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression. Ocul Immunol Inflamm. 2005;13(4):289–293. doi:10.1080/09273940490912407
   PubMed Web of Science ®Google Scholar
• Oh KT, Christmas NJ, Folk JC. Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. Am J Ophthalmol. 2002;133(5):622–629. doi:10.1016/s0002-9394(02)01350-8
   PubMed Web of Science ®Google Scholar
• Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Archives of Ophthalmology. 2001;119(9):1380–1383.
   PubMedGoogle Scholar
• Soubrane G, Bokobza R, Coscas G. Late developing lesions in birdshot retinochoroidopathy. Am J Ophthalmol. 1990;109(2):204–210. doi:10.1016/s0002-9394(14)75988-4
   PubMed Web of Science ®Google Scholar
• Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89(1):31–45. doi:10.1016/0002-9394(80)90226-3
   PubMed Web of Science ®Google Scholar